Serenus.AI, an innovative startup developing AI-based solutions to improve medical treatment decisions, obtained a Notice of Allowance from the US Patent and Trademark Office that the application ‘AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES’ will be registered as a US patent.
This patent, in addition to the company’s two patents-pending, adds to Serenus.AI’s deep intellectual property portfolio, and is focused on improving medical processes and decision-making before medical procedures and treatments.
Studies published in recent years show that a considerable proportion of medical procedures are unnecessary or inappropriate, endangering the lives of patients and causing a burden on healthcare systems by wasting valuable resources that could be better used elsewhere. This problem rapidly attains extreme proportions during extraordinary emergencies such as the novel Coronavirus (Sars-CoV-2) pandemic, which is putting a huge burden on health systems worldwide.
Serenus.AI CEO, Mrs. Hillary Orly Harel, stated: “Obtaining our US-patent, in additional to the two patents-pending, emphasizes the uniqueness and innovation that Serenus.AI brings to the US healthcare market, improving healthcare delivery and minimizing unnecessary risks while saving valuable resources.”